Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 randomized double-blind placebo-controlled trial of lurasidone in schizophrenia (Japan)
jRCT2080220563Phase 3
- Sponsor
- Sumitomo Pharma
- Start
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in schizophrenia comparing Lurasidone with Placebo (2 arms).
02
Drugs
lurasidone
03
Conditions
schizophrenia
Beyond the preview
Go deeper on jRCT2080220563.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220563.